We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

998:HKEXChina CITIC Bank Corporation Ltd Class H Analysis

Data as of 2026-09-05 - not real-time

HK$110.10

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Alibaba Group Holding Limited is neutral at HKD 110.10, with no clear ordering between short and long averages. Momentum indicators put RSI at 41.3 (neutral) with MACD reading bearish. The recent range runs from support at HKD 106.50 up to resistance at HKD 130.30.
Multiples put this in fair territory at a P/E of 25.4. The average analyst target implies 60.4% above today's level. Revenue is growing at 8.6% on a 7.0% profit margin. The 0.96% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 46.0%, a beta of 0.74 and a maximum drawdown of 51.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.

Top Market Events

BABA Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against...Alibaba Group Holding Limited NYSE:BABA is one of the Stocks with Potential to Explode in 2026.Alibaba Group Holding Limited NYSE:BABA is one of the Stocks with Potential to Explode in 2026.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Trading below the 200-day average of 133.05
  • MACD momentum is negative
  • 30-day volatility of 46.0%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 133.05
  • Analyst targets imply +60.4% versus the current price
  • 30-day volatility of 46.0%

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Analyst targets imply +60.4% versus the current price
  • Negative free cash flow
  • P/E ratio of 25.4

Key Metrics & Analysis

Financial Health

Revenue Growth8.60%
Profit Margin7.04%
P/E Ratio25.4
ROE6.36%
ROA1.56%
Debt/Equity23.93
P/B Ratio1.7
Op. Cash FlowHK$78.5B
Free Cash FlowHK$-82644123648

Technical Analysis

TrendNeutral
RSI41.3
SupportHK$106.50
ResistanceHK$130.30
MA 20HK$118.23
MA 50HK$113.51
MA 200HK$133.05
MACDBearish
VolumeIncreasing
Fear & Greed Index95.48

Valuation

Fair ValueHK$56.29
Target PriceHK$176.58
Upside/Downside60.38%
GradeFair
TypeBlend
Dividend Yield0.96%

Risk Assessment

Beta0.74
Volatility46.05%
Sector RiskHigh
Reg. RiskLow
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.